Environmental triggers of multiple sclerosis

FEBS Letters

Volumn 585, Issue 23, 2011, Pages 3724-3729

  Kakalacheva, Kristina ^a   Lünemann, Jan D ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Autoimmunity; Environment; Infection; Multiple sclerosis; Virus

Indexed keywords

25 HYDROXYVITAMIN D; AUTOANTIBODY; HLA DQ ANTIGEN; HLA DR ANTIGEN; VIRUS ANTIBODY;

ALLELE; ANTIGEN ANTIBODY REACTION; AUTOIMMUNITY; CHROMOSOME 6P; CIGARETTE SMOKING; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DRUG MEGADOSE; ENVIRONMENTAL FACTOR; EPSTEIN BARR VIRUS INFECTION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HERPES VIRUS INFECTION; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; HUMAN HERPESVIRUS 6; IMMUNOMODULATION; INFECTIOUS MONONUCLEOSIS; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK MANAGEMENT; SUN EXPOSURE; SYMPTOMATOLOGY; TORQUE TENO VIRUS; TORQUE TENO VIRUS INFECTION; VARICELLA ZOSTER VIRUS; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION;

ANIMALS; ENVIRONMENT; HUMANS; MULTIPLE SCLEROSIS; SMOKING; VITAMIN D;

HERPESVIRIDAE; HUMAN HERPESVIRUS 4;

EID: 80052250727     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2011.04.006     Document Type: Review

References (83)

1. L.F. Barcellos, S. Sawcer, P.P. Ramsay, S.E. Baranzini, G. Thomson, F. Briggs, B.C.A. Cree, A.B. Begovich, P. Villoslada, and X. Montalban Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis Hum. Mol. Genet. 2006 2813 2824 (Pubitemid 44400408)
2. C.R. Gale, and C.N. Martyn Migrant studies in multiple sclerosis Prog. Neurobiol. 1995 425 448 (Pubitemid 26022928)
3. G.C. Ebers, A.D. Sadovnick, and N.J. Risch A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group Nature 1995 150 151
4. A.D. Sadovnick, G.C. Ebers, D.A. Dyment, and N.J. Risch Evidence for genetic basis of multiple sclerosis. The Canadian Collaborative Study Group Lancet 1996 1728 1730 (Pubitemid 26187551)
5. D.A. Hafler, A. Compston, S. Sawcer, E.S. Lander, M.J. Daly, P.L. De Jager, P.I. de Bakker, S.B. Gabriel, D.B. Mirel, and A.J. Ivinson Risk alleles for multiple sclerosis identified by a genomewide study N. Engl. J. Med. 357 2007 851 862 10.1056/NEJMoa073493 (Pubitemid 47347319)
6. H.Q. Qu, J.P. Bradfield, A. Belisle, S.F. Grant, H. Hakonarson, and C. Polychronakos The type I diabetes association of the IL2RA locus Genes Immun. 10 Suppl 1 2009 S42 S48 10.1038/gene.2009.90
7. E.K. Wakeland, K. Liu, R.R. Graham, and T.W. Behrens Delineating the genetic basis of systemic lupus erythematosus Immunity 2001 397 408 (Pubitemid 32907387)
8. J.M. Charot Histologie de la sclerose en plaques Gaz. Hop. (Paris) 41 1868 554 555 557-558, 566
9. P. Marie Sclerose en plaques et maladie infecteuses Prog. Med. 12 1884 287 289
10. K. Luzuriaga, and J.L. SulliVan Infectious mononucleosis N. Engl. J. Med. 362 2010 1993 2000 10.1056/NEJMcp1001116
11. H.B. Warner, and R.I. Carp Multiple sclerosis and Epstein-Barr virus Lancet 2 1981 1290
12. E. Operskalski A case control study of multiple sclerosis Neurology 1989 825 829 (Pubitemid 19150160)
13. C. Lindberg, O. Andersen, A. Vahlne, M. Dalton, and B. Runmarker Epidemiological investigation of the association between infectious mononucleosis and multiple sclerosis Neuroepidemiology 1991 62 65
14. L.I. Levin, K.L. Munger, E.J. O'Reilly, K.I. Falk, and A. Ascherio Primary infection with the Epstein-Barr virus and risk of multiple sclerosis Ann. Neurol. 67 2010 824 830 10.1002/ana.21978
15. A.E. Handel, A.J. Williamson, G. Disanto, L. Handunnetthi, G. Giovannoni, and S.V. Ramagopalan An updated meta-analysis of risk of multiple sclerosis following infectious mononucleosis PLoS ONE 5 2010 10.1371/journal.pone.0012496
16. T.R. Nielsen, K. Rostgaard, J. Askling, R. Steffensen, A. Oturai, C. Jersild, N. Koch-Henriksen, P.S. Sørensen, and H. Hjalgrim Effects of infectious mononucleosis and HLA-DRB115 in multiple sclerosis Mult. Scler. 2009 431 436
17. D.S. Goodin The causal cascade to multiple sclerosis: A model for MS pathogenesis PLoS ONE 2009 e4565
18. S. Alotaibi Epstein-Barr virus in pediatric multiple sclerosis J. Am. Med. Assoc. 2004 1875 1879 (Pubitemid 38509501)
19. L.I. Levin, K.L. Munger, M.V. Rubertone, C.A. Peck, E.T. Lennette, D. Spiegelman, and A. Ascherio Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis JAMA: J. Am. Med. Assoc. 2005 2496 2500 (Pubitemid 40705731)
20. T. Nielsen Multiple sclerosis after infectious mononucleosis Arch. Neurol. 2007 72 75 (Pubitemid 46072426)
21. B.M. Zaadstra, A.M. Chorus, S. Van Buuren, H. Kalsbeek, and J.M. Van Noort Selective association of multiple sclerosis with infectious mononucleosis Mult. Scler. 2008 307 313 10.1177/1352458507084265 (Pubitemid 351676425)
22. G.N. DeLorenze, K.L. Munger, E.T. Lennette, N. Orentreich, J.H. Vogelman, and A. Ascherio Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up Arch. Neurol. 2006 839 844 (Pubitemid 43882291)
23. J.D. Lünemann, M. Tintoré, B. Messmer, T. Strowig, A. Rovira, H. Perkal, E. Caballero, C. Münz, X. Montalban, and M. Comabella Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis Ann. Neurol. 2010 159 169
24. J.D. Lünemann, P. Huppke, S. Roberts, W. Brück, J. Gärtner, and C. Münz Broadened and elevated humoral immune response to EBNA1 in pediatric multiple sclerosis Neurology 2008 1033 1035
25. J.D. Lunemann, N. Edwards, P.A. Muraro, S. Hayashi, J.I. Cohen, C. Munz, and R. Martin Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis Brain 129 2006 1493 1506 10.1093/brain/awl067 (Pubitemid 43999382)
26. J.D. Lünemann, I. Jelcić, S. Roberts, A. Lutterotti, B. Tackenberg, R. Martin, and C. Münz EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2 J. Exp. Med. 2008 1763 1773
27. D. Thorley-Lawson Epstein-Barr virus: exploiting the immune system Nat. Rev. Immunol. 2001 75 82 (Pubitemid 33741978)
28. B. Serafini, B. Rosicarelli, D. Franciotta, R. Magliozzi, R. Reynolds, P. Cinque, L. Andreoni, P. Trivedi, M. Salvetti, and A. Faggioni Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain J. Exp. Med. 2007 2899 2912 (Pubitemid 350179559)
29. S.N. Willis, C. Stadelmann, S.J. Rodig, T. Caron, S. Gattenloehner, S.S. Mallozzi, J.E. Roughan, S.E. Almendinger, M.M. Blewett, and W. Bruck Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain Brain 132 2009 3318 3328 10.1093/brain/awp200
30. L.A. Peferoen, F. Lamers, L.N. Lodder, W.H. Gerritsen, I. Huitinga, J. Melief, G. Giovannoni, U. Meier, R.Q. Hintzen, and G.M. Verjans Epstein-Barr virus is not a characteristic feature in the central nervous system in established multiple sclerosis Brain 133 2010 e137 10.1093/brain/awp296
31. S.A. Sargsyan, A.J. Shearer, A.M. Ritchie, M.P. Burgoon, S. Anderson, B. Hemmer, C. Stadelmann, S. Gattenlohner, G.P. Owens, and D. Gilden Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis Neurology 74 2010 1127 1135 10.1212/WNL.0b013e3181d865a1
32. A.V. Albright, E. Lavi, J.B. Black, S. Goldberg, M.J. O'Connor, and F. González-Scarano The effect of human herpesvirus-6 (HHV-6) on cultured human neural cells: oligodendrocytes and microglia J. Neurovirol. 1998 486 494 (Pubitemid 28499344)
33. P.K. Chan, H.K. Ng, and A.F. Cheng Detection of human herpesviruses 6 and 7 genomic sequences in brain tumours J. Clin. Pathol. 1999 620 623 (Pubitemid 29371909)
34. D.H. Dockrell, T.F. Smith, and C.V. Paya Human herpesvirus 6 Mayo Clin. Proc. 1999 163 170 (Pubitemid 29085214)
35. J.S. Kim, K.S. Lee, J.H. Park, M.Y. Kim, and W.S. Shin Detection of human herpesvirus 6 variant A in peripheral blood mononuclear cells from multiple sclerosis patients Eur. Neurol. 2000 170 173
36. M.L. Opsahl, and P.G.E. Kennedy Early and late HHV-6 gene transcripts in multiple sclerosis lesions and normal appearing white matter Brain 2005 516 527 (Pubitemid 40380187)
37. P.B. Challoner, K.T. Smith, J.D. Parker, D.L. MacLeod, S.N. Coulter, T.M. Rose, E.R. Schultz, J.L. Bennett, R.L. Garber, and M. Chang Plaque-associated expression of human herpesvirus 6 in multiple sclerosis Proc. Natl Acad. Sci. USA 1995 7440 7444
38. P. Mirandola, A. Stefan, E. Brambilla, G. Campadelli-Fiume, and L.M. Grimaldi Absence of human herpesvirus 6 and 7 from spinal fluid and serum of multiple sclerosis patients Neurology 1999 1367 1368 (Pubitemid 29480112)
39. M.V. Tejada-Simon, Y.C.Q. Zang, J. Hong, V.M. Rivera, and J.Z. Zhang Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis Ann. Neurol. 2003 189 197 (Pubitemid 36164000)
40. S.V. Ramagopalan, W. Valdar, D.A. Dyment, G.C. DeLuca, I.M. Yee, G. Giovannoni, G.C. Ebers, A.D. Sadovnick, and C.C.S. Group Association of infectious mononucleosis with multiple sclerosis. A population-based study Neuroepidemiology 2009 257 262
41. D.W. Barnes, and R.J. Whitley CNS diseases associated with varicella zoster virus and herpes simplex virus infection. Pathogenesis and current therapy Neurol. Clin. 1986 265 283 (Pubitemid 16022689)
42. R.B. Tenser Herpes simplex and herpes zoster. Nervous system involvement Neurol. Clin. 1984 215 240
43. R.A. Marrie, and C. Wolfson Multiple sclerosis and varicella zoster virus infection: A review Epidemiol. Infect. 2001 315 325 (Pubitemid 33019543)
44. G. Ordoñez, B. Pineda, R. Garcia-Navarrete, and J. Sotelo Brief presence of varicella-zoster viral DNA in mononuclear cells during relapses of multiple sclerosis Arch. Neurol. 2004 529 532 (Pubitemid 38923742)
45. R. Mancuso, S. Delbue, E. Borghi, E. Pagani, M.G. Calvo, D. Caputo, E. Granieri, and P. Ferrante Increased prevalence of varicella zoster virus DNA in cerebrospinal fluid from patients with multiple sclerosis J. Med. Virol. 79 2007 192 199 10.1002/jmv.20777 (Pubitemid 46048509)
46. J. Sotelo, A. Martínez-Palomo, G. Ordoñez, and B. Pineda Varicella-zoster virus in cerebrospinal fluid at relapses of multiple sclerosis Ann. Neurol. 2008 303 311 (Pubitemid 351506349)
47. M.P. Burgoon, R.J. Cohrs, J.L. Bennett, S.W. Anderson, A.M. Ritchie, S. Cepok, B. Hemmer, D. Gilden, and G.P. Owens Varicella zoster virus is not a disease-relevant antigen in multiple sclerosis Ann. Neurol. 2009 474 479
48. M. Sospedra, Y. Zhao, H. zur Hausen, P.A. Muraro, C. Hamashin, E.-M. de Villiers, C. Pinilla, and R. Martin Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity PLoS Pathog. 2005 e41
49. W. Gaisford, and A. Cooke Can infections protect against autoimmunity? Curr. Opin. Rheumatol. 21 2009 391 396 10.1097/BOR.0b013e32832c2dee
50. A.C. La Flamme, K. Ruddenklau, and B.T. Backstrom Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis Infect. Immun. 71 2003 4996 5004 (Pubitemid 37070742)
51. K.P. Walsh, M.T. Brady, C.M. Finlay, L. Boon, and K.H. Mills Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses J. Immunol. 183 2009 1577 1586 10.4049/jimmunol.0803803
52. J. Correale, and M. Farez Association between parasite infection and immune responses in multiple sclerosis Ann. Neurol. 61 2007 97 108 10.1002/ana.21067 (Pubitemid 46363837)
53. Fleming, J. O. (2011) Helminths and multiple sclerosis: will old friends give us new treatments for MS? J. Neuroimmunol. doi:10.1016/j.jneuroim.2011.01. 003.
54. J.M. Lemire Immunomodulatory actions of 1,25-dihydroxyvitamin D3 J. Steroid Biochem. Mol. Biol. 53 1995 599 602
55. E. May, K. Asadullah, and U. Zugel Immunoregulation through 1,25-dihydroxyvitamin D3 and its analogs Curr. Drug Targets Inflamm. Allergy 3 2004 377 393 (Pubitemid 39534774)
56. C. Pierrot-Deseilligny, and J.C. Souberbielle Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis? Brain 133 2010 1869 1888 10.1093/brain/awq147
57. J.F. Kurtzke, G.W. Beebe, and J.E. Norman Jr Epidemiology of multiple sclerosis in U.S. veterans: 1. Race, sex, and geographic distribution Neurology 29 1979 1228 1235 (Pubitemid 9231587)
58. E.D. Acheson, C.A. Bachrach, and F.M. Wright Some comments on the relationship of the distribution of multiple sclerosis to latitude, solar radiation, and other variables Acta Psychiatr. Scand. Suppl. 1960 132 147
59. D.H. Miller, S.R. Hammond, J.G. McLeod, G. Purdie, and D.C. Skegg Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental? J. Neurol. Neurosurg. Psychiatry 53 1990 903 905 (Pubitemid 20351058)
60. S. Vukusic, V. Van Bockstael, S. Gosselin, and C. Confavreux Regional variations in the prevalence of multiple sclerosis in French farmers J. Neurol. Neurosurg. Psychiatry 78 2007 707 709 10.1136/jnnp. 2006.101196 (Pubitemid 46998840)
61. K.C. Simon, I.A.F. Van Der Mei, K.L. Munger, A. Ponsonby, J. Dickinson, T. Dwyer, P. Sundström, and A. Ascherio Combined effects of smoking, anti-EBNA antibodies, and HLA-DRB11501 on multiple sclerosis risk Neurology 2010 1365 1371
62. P. Goldberg Multiple sclerosis: vitamin D and calcium as environmental determinants of prevalence (a viewpoint). Part 1: sunlight, dietary factors and epidemiology Tern. J. Environ. Stud. 6 1974 19 27
63. R.L. Swank, O. Lerstad, A. Strom, and J. Backer Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition N. Engl. J. Med. 246 1952 722 728
64. K. Westlund Distribution and mortality time trend of multiple sclerosis and some other diseases in Norway Acta Neurol. Scand. 46 1970 455 483
65. C.J. Willer, D.A. Dyment, A.D. Sadovnick, P.M. Rothwell, T.J. Murray, G.C. Ebers, and C.C.S. Group Timing of birth and risk of multiple sclerosis: population based study BMJ 2005 120
66. T. Islam, W.J. Gauderman, W. Cozen, and T.M. Mack Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins Neurology 2007 381 388 (Pubitemid 47205666)
67. R.M. Lucas, A.L. Ponsonby, K. Dear, P.C. Valery, M.P. Pender, B.V. Taylor, T.J. Kilpatrick, T. Dwyer, A. Coulthard, and C. Chapman Sun exposure and vitamin D are independent risk factors for CNS demyelination Neurology 76 2011 540 548 10.1212/WNL.0b013e31820af93d
68. K.L. Munger, L.I. Levin, B.W. Hollis, N.S. Howard, and A. Ascherio Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis JAMA: J. Am. Med. Assoc. 2006 2832 2838 (Pubitemid 44969183)
69. D.P. Auer, E.M. Schumann, T. Kumpfel, C. Gossl, and C. TrenkwalDer Seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis Ann. Neurol. 47 2000 276 277 (Pubitemid 30078583)
70. H. Tremlett, I.A.F. Van Der Mei, F. Pittas, L. Blizzard, G. Paley, D. Mesaros, R. Woodbaker, M. Nunez, T. Dwyer, and B.V. Taylor Monthly ambient sunlight, infections and relapse rates in multiple sclerosis Neuroepidemiology 2008 271 279
71. M.S. Barnes, M.P. Bonham, P.J. Robson, J.J. Strain, A.S. Lowe-Strong, J. Eaton-Evans, F. Ginty, and J.M. Wallace Assessment of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D3 concentrations in male and female multiple sclerosis patients and control volunteers Mult. Scler. 13 2007 670 672 10.1177/1352458506072666 (Pubitemid 46939536)
72. I.A. Van Der Mei, A.L. Ponsonby, T. Dwyer, L. Blizzard, B.V. Taylor, T. Kilpatrick, H. Butzkueven, and A.J. McMichael Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia J. Neurol. 254 2007 581 590 10.1007/s00415-006-0315-8 (Pubitemid 46781963)
73. E.M. Mowry, L.B. Krupp, M. Milazzo, D. Chabas, J.B. Strober, A.L. Belman, J.C. McDonald, J.R. Oksenberg, P. Bacchetti, and E. Waubant Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis Ann. Neurol. 67 2010 618 624 10.1002/ana.21972
74. J. Smolders, P. Menheere, A. Kessels, J. Damoiseaux, and R. Hupperts Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis Mult. Scler. 2008 1220 1224
75. T. Holmøy, S.M. Moen, T.A. Gundersen, M.F. Holick, E. Fainardi, M. Castellazzi, and I. Casetta 25-Hydroxyvitamin D in cerebrospinal fluid during relapse and remission of multiple sclerosis Mult. Scler. 2009 1280 1285
76. L.E. Bartels, C.L. Hvas, J. Agnholt, J.F. Dahlerup, and R. Agger Human dendritic cell antigen presentation and chemotaxis are inhibited by intrinsic 25-hydroxy vitamin D activation Int. Immunopharmacol. 10 2010 922 928 10.1016/j.intimp. 2010.05.003
77. C.G. Mayne, J.A. Spanier, L.M. Relland, C.B. Williams, and C.E. Hayes 1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis Eur. J. Immunol. 2011 n/a-n/a
78. S.M. Kimball, M.R. Ursell, P. O'Connor, and R. Vieth Safety of vitamin D3 in adults with multiple sclerosis Am. J. Clin. Nutr. 2007 645 651 (Pubitemid 47435831)
79. D.M. Wingerchuk, J. Lesaux, G.P. Rice, M. Kremenchutzky, and G.C. Ebers A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis J. Neurol. Neurosurg. Psychiatry 2005 1294 1296 10.1136/jnnp. 2004.056499 (Pubitemid 41208389)
80. A.E. Handel, A.J. Williamson, G. Disanto, R. Dobson, G. Giovannoni, and S.V. Ramagopalan Smoking and multiple sclerosis: an updated meta-analysis PLoS ONE 2011 e16149
81. A.K. Hedstrom, E. Sundqvist, M. Baarnhielm, N. Nordin, J. Hillert, I. Kockum, T. Olsson, and L. Alfredsson Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis Brain 134 2011 653 664 10.1093/brain/awq371
82. A.K. Hedström, M. Bäärnhielm, T. Olsson, and L. Alfredsson Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis Neurology 2009 696 701
83. C. Carlens, M.-P. Hergens, J. Grunewald, A. Ekbom, A. Eklund, C.O. Höglund, and J. Askling Smoking, use of moist snuff, and risk of chronic inflammatory diseases Am. J. Respir. Crit. Care Med. 2010 1217 1222